Managers

Gaorong collects $450 mln for fourth fund

Chinese venture firm Gaorong Capital has raised $450 million for its fourth fund, according to an SEC filing. Gaorong Capital focuses on early and growth stage investments in TMT, including AI and frontier technologies, consumption and retail, fintech and enterprise services.

Rheostat Therapeutics inks $23 mln Series A

Cambridge, Massachusetts-based Rheostat Therapeutics, a biotech company focused on treating neurodegeneration, cognition and rare diseases, has raised $23 million in Series A financing. MRLV and AbbVie Ventures led the round.

Draper Espirit leads $31 mln round for Fluidic Analytics

UK-based Fluidic Analytics Ltd, a developer of tools that analyze proteins and other biomolecular species, has raised $31 million in funding. Draper Esprit led the round with participation from Delin Ventures, BGF, IQ Capital and Amadeus Capital Partners.

VC-backed BlueRock Therapeutics names chief legal and administrative officer

Cambridge, Massachusetts-based BlueRock Therapeutics LP, a cell therapy company, has named Dr. Min Wang as chief legal and administrative officer. Previously, she worked at Agios Pharmaceuticals where she was vice president, general counsel and corporate secretary. BlueRock is backed by Bayer AG and Versant Ventures.

Larger VC funds outperform smaller funds in 2017

Real estate investing dropped in October

Japanese telecom company's NTT Communications raises $500 mln for venture fund

NTT Venture Capital has raised $500 million for its new fund, according to an SEC filing. NTT Venture Capital is Japanese telecom company's NTT Communications' venture fund. Vab Goel, former general partner at Norwest Venture Partners, led the fund.

NFP Ventures invests in Nubundle

Nubundle, a holistic family planning and fertility services company, has secured an undisclosed amount of funding. The investor was NFP Ventures.

Cultivate(MD) backs Medical Ingenuities

Genesis Innovation Group's Cultivate(MD) has made an investment in Wheaton, Illinois-based Medical Ingenuities LLC, a medical device company. No financial terms were disclosed.

Stilla Technologies attracts $18 mln Series A

Stilla Technologies, a European provider of digital PCR solutions for high precision genetic analysis, has closed $18 million in Series A financing. Illumina Ventures led the round with participation from Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds and Idinvest Partners. In addition to the financing, Nick Naclerio of Illumina Ventures, Philippe Peltier of Kurma Partners and Philippe Chambon of LBO France have joined Stilla's board of directors.